These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34298825)

  • 1. Canopy Homolog 2 as a Novel Molecular Target in Hepatocarcinogenesis.
    Kakehashi A; Suzuki S; Shiota M; Raymo N; Gi M; Tachibana T; Stefanov V; Wanibuchi H
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
    Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
    Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canopy Homolog 2 contributes to liver oncogenesis by promoting unfolded protein response-dependent destabilization of tumor protein P53.
    Hong F; Lin CY; Yan J; Dong Y; Ouyang Y; Kim D; Zhang X; Liu B; Sun S; Gu W; Li Z
    Hepatology; 2022 Dec; 76(6):1587-1601. PubMed ID: 34986508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockout of Canopy 2 activates p16
    Yin W; Guo J; Zhang C; Alibhai FJ; Li SH; Billia P; Wu J; Yau TM; Weisel RD; Li RK
    J Mol Cell Cardiol; 2019 Jul; 132():36-48. PubMed ID: 31047986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
    Kakehashi A; Chariyakornkul A; Suzuki S; Khuanphram N; Tatsumi K; Yamano S; Fujioka M; Gi M; Wongpoomchai R; Wanibuchi H
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis.
    Kakehashi A; Ishii N; Shibata T; Wei M; Okazaki E; Tachibana T; Fukushima S; Wanibuchi H
    Toxicol Sci; 2011 Jan; 119(1):61-72. PubMed ID: 20935162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.
    Kakehashi A; Kato A; Inoue M; Ishii N; Okazaki E; Wei M; Tachibana T; Wanibuchi H
    Toxicol Appl Pharmacol; 2010 Jan; 242(1):47-55. PubMed ID: 19796649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A secreted protein (Canopy 2, CNPY2) enhances angiogenesis and promotes smooth muscle cell migration and proliferation.
    Guo J; Zhang Y; Mihic A; Li SH; Sun Z; Shao Z; Wu J; Weisel RD; Li RK
    Cardiovasc Res; 2015 Mar; 105(3):383-93. PubMed ID: 25589425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
    Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
    Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF; Ng IO
    Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
    Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells.
    Ito S; Ueno A; Ueda T; Nakagawa H; Taniguchi H; Kayukawa N; Fujihara-Iwata A; Hongo F; Okihara K; Ukimura O
    Oncotarget; 2018 Apr; 9(25):17645-17655. PubMed ID: 29707137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy.
    Guo J; Mihic A; Wu J; Zhang Y; Singh K; Dhingra S; Weisel RD; Li RK
    Eur Heart J; 2015 Oct; 36(37):2530-40. PubMed ID: 26160001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis.
    Pok S; Wen V; Shackel N; Alsop A; Pyakurel P; Fahrer A; Farrell GC; Teoh NC
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1545-54. PubMed ID: 23574010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
    Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
    Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CNPY2 in mouse tissues: quantification and localization.
    Hatta K; Guo J; Ludke A; Dhingra S; Singh K; Huang ML; Weisel RD; Li RK
    PLoS One; 2014; 9(11):e111370. PubMed ID: 25393402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3β pathway in non-small cell lung cancer.
    Dou Y; Lei JQ; Guo SL; Zhao D; Yue HM; Yu Q
    Cell Biol Int; 2018 Aug; 42(8):959-964. PubMed ID: 29569784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNPY2 enhances resistance to apoptosis induced by cisplatin via activation of NF-κB pathway in human non-small cell lung cancer.
    Yu D; Qin Y; Jun-Qiang L; Shun-Lin G
    Biomed Pharmacother; 2018 Jul; 103():1658-1663. PubMed ID: 29864955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis.
    Pok S; Barn VA; Wong HJ; Blackburn AC; Board P; Farrell GC; Teoh NC
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1210-9. PubMed ID: 26574916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.